It is the best of times; it is the worst of times: is there a way forward? A plethora of treatment options for rheumatoid arthritis, but critical trial design issues.
James R
JR
O'Dell
D018501:Antirheumatic Agents / Q000191:economics / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000941:ethics / Q000379:methods / Q000639:trends*; D003362:Cost-Benefit Analysis; D006801:Humans
D018501:Antirheumatic Agents